← Open Payments lookup

MARK SCANLAN: Open Payments

NPI 1013933274 · SCOTTSBLUFF, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$800 in 59 payments from 10 companies in 2025. Trend: 2023 $628 · 2024 $866 · 2025 $800

Food & beverage: $800
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.24$303
Teva Pharmaceuticals USA, Inc.22$240
Janssen Pharmaceuticals, Inc4$66
E.R. Squibb & Sons, L.L.C.3$57
Lundbeck LLC1$26
Neuronetics, Inc.1$24
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$22
ABBVIE INC.1$22
Axsome Therapeutics, Inc.1$21
IDORSIA PHARMACEUTICALS US INC1$19

Products named: ABILIFY MAINTENA, REXULTI, UZEDY, AUSTEDO XR, COBENFY, INVEGA SUSTENNA, NEUROSTAR TMS THERAPY SYSTEM, CAPLYTA.

Industry payments across NE — which companies pay providers there.